Literature DB >> 22897624

Patients' attitudes and perceptions of implantable cardioverter-defibrillators: potential barriers to appropriate primary prophylaxis.

Jennifer Yuhas1, Kristin Mattocks, Laura Gravelin, Michael Remetz, John Foley, Richard Fazio, Rachel Lampert.   

Abstract

BACKGROUND: Primary prophylaxis with implantable cardioverter-defibrillators (ICDs) improves mortality in patients at risk for sudden cardiac death (SCD). However, ICDs are highly underutilized. We explored patients' attitudes and perceptions of ICDs to better understand potential patient-related barriers to appropriate utilization.
METHODS: Records of patients visiting three outpatient cardiology clinics (June 2009-January 2010) were reviewed and 133 with ejection fractions ≤35% and without an ICD were identified. Seventy-two met criteria for ICD placement. Twenty-five consented and were interviewed by telephone using a semistructured open-ended interview guide. Twelve individuals had accepted ICD referral, and 13 had declined. We analyzed transcripts of ICD refusers and acceptors using the constant comparative method of grounded theory.
RESULTS: Five major themes emerged: (1) Patients who refused ICD referral demonstrated a lack of insight into their own risk potential. (2) Many patients who accepted ICD referral perceived that this was strongly recommended by their physicians, although many patients refusing did not. (3) Concerns over recall, malfunction, and surgical risk were common in both. (4) Many patients demonstrated inaccurate perceptions of ICD-related risks and lifestyle changes. Acceptors often reported these perceptions being addressed by their physician. (5) Feelings regarding invasive life-prolonging interventions played an important role in ICD referral refusal for some individuals.
CONCLUSIONS: Refusal of ICD is common among primary prevention candidates. Common themes in the decision-making process include insight into personal risk of SCD, and perceived strength of the physician recommendation. Providers may want to consider assessment of patients' individual understanding and perceptions when discussing ICD prophylaxis. ©2012, The Authors. Journal compilation ©2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22897624     DOI: 10.1111/j.1540-8159.2012.03497.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  10 in total

1.  Eligibility for subcutaneous implantable cardioverter-defibrillator in congenital heart disease.

Authors:  Linda Wang; Neeraj Javadekar; Ananya Rajagopalan; Nichole M Rogovoy; Kazi T Haq; Craig S Broberg; Larisa G Tereshchenko
Journal:  Heart Rhythm       Date:  2020-05       Impact factor: 6.343

Review 2.  Implantable Cardioverter-Defibrillator Use in Older Adults: Proceedings of a Hartford Change AGEnts Symposium.

Authors:  Daniel B Kramer; Daniel D Matlock; Alfred E Buxton; Nathan E Goldstein; Carol Goodwin; Ariel R Green; James N Kirkpatrick; Christopher Knoepke; Rachel Lampert; Paul S Mueller; Matthew R Reynolds; John A Spertus; Lynne W Stevenson; Susan L Mitchell
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-06-02

3.  Patients' knowledge and concerns about using the implantable cardioverter defibrillator for the primary prevention of sudden cardiac death and its correlates: A cross-sectional study.

Authors:  Mohammad A Zakeri; Nadia Sedri; Golamreza Bazmandegan; Maryam Zakeri; Mohammad Safariyan; Mahlagha Dehghan
Journal:  Health Sci Rep       Date:  2022-06-13

Review 4.  Making decisions about implantable cardioverter-defibrillators from implantation to end of life: an integrative review of patients' perspectives.

Authors:  Krystina B Lewis; Dawn Stacey; Dan D Matlock
Journal:  Patient       Date:  2014       Impact factor: 3.883

5.  Patient barriers to implantable cardioverter defibrillator implantation for the primary prevention of sudden cardiac death in patients with heart failure and reduced ejection fraction.

Authors:  Laura Lihua Chan; Choon Pin Lim; Soe Tin Aung; Paul Quetua; Kah Leng Ho; Daniel Chong; Wee Siong Teo; David Sim; Chi Keong Ching
Journal:  Singapore Med J       Date:  2016-04       Impact factor: 1.858

Review 6.  2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.

Authors:  Paul A Heidenreich; Gregg C Fonarow; Khadijah Breathett; Corrine Y Jurgens; Barbara A Pisani; Bunny J Pozehl; John A Spertus; Kenneth G Taylor; Jennifer T Thibodeau; Clyde W Yancy; Boback Ziaeian
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-11-02

7.  Clinician time used for decision making: a best case workflow study using cardiovascular risk assessments and Ask Mayo Expert algorithmic care process models.

Authors:  Frederick North; Samuel Fox; Rajeev Chaudhry
Journal:  BMC Med Inform Decis Mak       Date:  2016-07-20       Impact factor: 2.796

8.  Association between implantable cardioverter-defibrillator and survival in patients awaiting heart transplantation: A meta-analysis and systematic review.

Authors:  Andrew Y Lin; Jason M Duran; Alexandra Sykes; Douglas Darden; Marcus Urey; Jonathan C Hsu; Eric D Adler; Ulrika Birgersdotter-Green
Journal:  Heart Rhythm O2       Date:  2021-12-17

9.  2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.

Authors:  Paul A Heidenreich; Gregg C Fonarow; Khadijah Breathett; Corrine Y Jurgens; Barbara A Pisani; Bunny J Pozehl; John A Spertus; Kenneth G Taylor; Jennifer T Thibodeau; Clyde W Yancy; Boback Ziaeian
Journal:  J Am Coll Cardiol       Date:  2020-11-02       Impact factor: 24.094

10.  Influence of primary and secondary prevention indications on anxiety about the implantable cardioverter-defibrillator.

Authors:  Anita Rahmawati; Akiko Chishaki; Tomoko Ohkusa; Hiroyuki Sawatari; Miyuki Tsuchihashi-Makaya; Yuko Ohtsuka; Mori Nakai; Mami Miyazono; Nobuko Hashiguchi; Harumizu Sakurada; Masao Takemoto; Yasushi Mukai; Shujirou Inoue; Kenji Sunagawa; Hiroaki Chishaki
Journal:  J Arrhythm       Date:  2015-11-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.